Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Hair transplantation improves life quality by addressing scars, aging, and genetic flaws, but is limited by the availability of the patient's own hair for donation.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

PRP therapy increases hair density for androgenetic alopecia.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The letter criticizes a study's methods and small size, suggesting larger, better-designed research would show low-level light therapy effectively grows hair.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Combination therapy promotes better hair growth and density.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Low-level laser therapy is a safe and effective treatment for hair loss.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Estrogen therapy can reduce skin aging but has cancer risks.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.